Peloton Therapeutics, Inc. Dallas, TX 75235-7323 April 22, 2019 Alan Musso c/o Peloton Therapeutics, Inc. Dear Alan:Letter Agreement • April 26th, 2019 • Peloton Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 26th, 2019 Company IndustryThis letter agreement (the “Agreement”) is entered into between you and Peloton Therapeutics, Inc. (the “Company” or “we”), effective as of April 22, 2019 (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date.
Peloton Therapeutics, Inc. Dallas, TX 75235-7323 April 22, 2019 Mohammad Hirmand, M.D. c/o Peloton Therapeutics, Inc. Dear Mohammad:Letter Agreement • April 26th, 2019 • Peloton Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 26th, 2019 Company IndustryThis letter agreement (the “Agreement”) is entered into between you and Peloton Therapeutics, Inc. (the “Company” or “we”), effective as of April 22, 2019 (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date.
Peloton Therapeutics, Inc. Dallas, TX 75235-7323 April 22, 2019 John R. Moore c/o Peloton Therapeutics, Inc. Dear John:Letter Agreement • April 26th, 2019 • Peloton Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 26th, 2019 Company IndustryThis letter agreement (the “Agreement”) is entered into between you and Peloton Therapeutics, Inc. (the “Company” or “we”), effective as of April 22, 2019 (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date.
Peloton Therapeutics, Inc. Dallas, TX 75235-7323 April 22, 2019 Eli M. Wallace, Ph.D. c/o Peloton Therapeutics, Inc. Dear Eli:Letter Agreement • April 26th, 2019 • Peloton Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 26th, 2019 Company IndustryThis letter agreement (the “Agreement”) is entered into between you and Peloton Therapeutics, Inc. (the “Company” or “we”), effective as of April 22, 2019 (the “Effective Date”), to confirm the terms and conditions of your employment with the Company as of the Effective Date. This Agreement supersedes and replaces any and all employment terms, compensation, or benefits you may have had or to which you may have been entitled prior to the Effective Date.